Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease
- PMID: 17494108
- DOI: 10.1136/gut.2006.111609
Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease
Abstract
Background: Coeliac disease is caused by an immune response to gluten. As gluten proteins are proline rich they are resistant to enzymatic digestion in the gastrointestinal tract, a property that probably contributes to the immunogenic nature of gluten.
Aims: This study determined the efficiency of gluten degradation by a post-proline cutting enzyme, Aspergillus niger prolyl endoprotease (AN-PEP), in a dynamic system that closely mimics the human gastrointestinal tract (TIM system).
Methods: Two experiments were performed. In the first, a slice of bread was processed in the TIM system with and without co-administration of AN-PEP. In the second, a standard fast food menu was used. Samples of the digesting meals were taken from the stomach, duodenum, jejunum and ileum compartments at time zero until 4 hours after the start of the experiment. In these samples the levels of immunogenic peptides from gliadins and glutenins were assessed by monoclonal antibody-based competition assays, Western blot analysis and proliferation T-cell assays.
Results: AN-PEP accelerated the degradation of gluten in the stomach compartment to such an extent that hardly any gluten reached the duodenum compartment.
Conclusion: AN-PEP is capable of accelerating the degradation of gluten in a gastrointestinal system that closely mimics in-vivo digestion. This implies that the co-administration of AN-PEP with a gluten-containing meal might eliminate gluten toxicity, thus offering patients the possibility of abandoning (occasionally) their strict gluten-free diet.
Similar articles
-
Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease.Am J Physiol Gastrointest Liver Physiol. 2006 Oct;291(4):G621-9. doi: 10.1152/ajpgi.00034.2006. Epub 2006 May 11. Am J Physiol Gastrointest Liver Physiol. 2006. PMID: 16690904
-
Influence of dietary components on Aspergillus niger prolyl endoprotease mediated gluten degradation.Food Chem. 2015 May 1;174:440-5. doi: 10.1016/j.foodchem.2014.11.053. Epub 2014 Nov 14. Food Chem. 2015. PMID: 25529703
-
Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue.Gastroenterology. 2007 Aug;133(2):472-80. doi: 10.1053/j.gastro.2007.05.028. Epub 2007 May 21. Gastroenterology. 2007. PMID: 17681168
-
Gluten Degrading Enzymes for Treatment of Celiac Disease.Nutrients. 2020 Jul 15;12(7):2095. doi: 10.3390/nu12072095. Nutrients. 2020. PMID: 32679754 Free PMC article. Review.
-
Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease.Gastroenterology. 2005 Sep;129(3):786-96. doi: 10.1053/j.gastro.2005.06.016. Gastroenterology. 2005. PMID: 16143118 Review.
Cited by
-
Targeting proline in (phospho)proteomics.FEBS J. 2020 Jul;287(14):2979-2997. doi: 10.1111/febs.15190. Epub 2020 Jan 13. FEBS J. 2020. PMID: 31863553 Free PMC article.
-
Autoimmune phenotypes in schizophrenia reveal novel treatment targets.Pharmacol Ther. 2018 Sep;189:184-198. doi: 10.1016/j.pharmthera.2018.05.005. Epub 2018 May 6. Pharmacol Ther. 2018. PMID: 29742478 Free PMC article. Review.
-
Non-dietary forms of treatment for adult celiac disease.World J Gastrointest Pharmacol Ther. 2013 Nov 6;4(4):108-12. doi: 10.4292/wjgpt.v4.i4.108. World J Gastrointest Pharmacol Ther. 2013. PMID: 24199026 Free PMC article. Review.
-
Despite sequence homologies to gluten, salivary proline-rich proteins do not elicit immune responses central to the pathogenesis of celiac disease.Am J Physiol Gastrointest Liver Physiol. 2015 Dec 1;309(11):G910-7. doi: 10.1152/ajpgi.00157.2015. Epub 2015 Oct 1. Am J Physiol Gastrointest Liver Physiol. 2015. PMID: 26505973 Free PMC article.
-
Effect of Aspergillus niger prolyl endopeptidase in patients with celiac disease on a long-term gluten-free diet.World J Gastroenterol. 2024 Mar 21;30(11):1545-1555. doi: 10.3748/wjg.v30.i11.1545. World J Gastroenterol. 2024. PMID: 38617446 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous